SIRT1 and cancer: SIRT1 is also over-expressed and required for cell survival in pancreatic cancers [21,22], has been implicated in the non-solid tumour chronic myelogenous leukaemia [23,24] and suggested as an anti-cancer target for medulloblastoma [25,26].